Crinetics Pharmaceuticals, Inc. (CRNX)

NASDAQ: CRNX · Real-Time Price · USD

83.85

+0.12 (0.14%)

At close: Jul 27, 2026, 4:00 PM EDT

83.63

-0.22 (-0.26%)

After-hours: Jul 27, 2026, 7:34 PM EDT

Crinetics Pharmaceuticals Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	1.17	7.7	1.04	4.01	4.74	1.08
Revenue Growth	194.24%	640.71%	-74.11%	-15.28%	339.43%	1418.31%
Gross Profit	1.17	6.62	1.04	4.01	4.74	1.08
Operating Income	-545.74	-516.77	-338.85	-222.61	-167.88	-107.7
Net Income	-496.39	-465.32	-298.41	-214.53	-163.92	-107.64
Earnings Per Share	-5.13	-4.95	-3.69	-3.69	-3.15	-2.80
EPS Growth	-	-	-	-	-	-

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Product Net	5.42	-	-
Collaboration and License	2.28	1.04	4.01
Revenue (Total)	7.7	1.04	4.01

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	1,291	1,028	1,354	558.56	334.43	333.71
Total Debt	47.86	48.54	51.72	51.73	3.08	3.07
Net Cash (Debt)	1,243	979.35	1,302	506.83	331.35	330.63
Net Cash Growth	1.65%	-24.80%	156.96%	52.96%	0.22%	98.14%
Net Cash Per Share	12.85	10.41	16.12	8.73	6.37	8.60

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	-414.17	-377.92	-230.19	-168.6	-115.21	-88.59
Capital Expenditures	-5.34	-5.76	-3.84	-4.69	-1.66	-0.44
Free Cash Flow	-419.52	-383.68	-234.04	-173.29	-116.86	-89.02
Free Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	100.00%	86.02%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-46485.70%	-6714.77%	-32613.50%	-5547.17%	-3544.06%	-9990.91%
Pretax Margin	-42266.44%	-6046.22%	-28675.46%	-5216.32%	-3439.05%	-9985.25%
Profit Margin	-42281.80%	-6046.22%	-28720.70%	-5345.85%	-3460.38%	-9985.25%
FCF Margin	-35733.90%	-4985.50%	-22525.30%	-4318.12%	-2466.98%	-8258.26%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PS Ratio	489.30	578.10	4572.96	604.45	208.14	1254.39